Cargando…

Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer

INTRODUCTION: The aim of this study was to compare two groups of patients with early stage cervical cancer who underwent either abdominal or vaginal surgery, in terms of post-operative findings and survival. MATERIALS AND METHODOLOGY: 55 patients with diagnosed cervical cancer were retrospectively s...

Descripción completa

Detalles Bibliográficos
Autores principales: Larciprete, Giovanni, Malandrenis, Ioannis, Pierro, Giuseppe Di, Montagnoli, Carlotta, Rossi, Federica, Centonze, Chiara, Bompiani, Alessandro, Panetta, Valentina, Valli, Edoardo, Segatore, Mario, Valensise, Herbert, Cirese, Elio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Master Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884790/
https://www.ncbi.nlm.nih.gov/pubmed/24711756
_version_ 1782298650450329600
author Larciprete, Giovanni
Malandrenis, Ioannis
Pierro, Giuseppe Di
Montagnoli, Carlotta
Rossi, Federica
Centonze, Chiara
Bompiani, Alessandro
Panetta, Valentina
Valli, Edoardo
Segatore, Mario
Valensise, Herbert
Cirese, Elio
author_facet Larciprete, Giovanni
Malandrenis, Ioannis
Pierro, Giuseppe Di
Montagnoli, Carlotta
Rossi, Federica
Centonze, Chiara
Bompiani, Alessandro
Panetta, Valentina
Valli, Edoardo
Segatore, Mario
Valensise, Herbert
Cirese, Elio
author_sort Larciprete, Giovanni
collection PubMed
description INTRODUCTION: The aim of this study was to compare two groups of patients with early stage cervical cancer who underwent either abdominal or vaginal surgery, in terms of post-operative findings and survival. MATERIALS AND METHODOLOGY: 55 patients with diagnosed cervical cancer were retrospectively selected for this study. They were preoperatively staged according to FIGO criteria. Forty four patients had disease between stages Ib and IIa with no evidence of extra-pelvic lymph node involvement and 10 patients had stage ≥ IIb. RESULTS: Of the 55 patients, 17 had been operated by Schauta-Amreich radical vaginal hysterectomy and 38 by Piver type II abdominal hysterectomy. No significant statistical differences have been found between two groups about age (median age was 49 for Schauta and 54 for Piver p=0.494) and parity of the patients (Median parity was 2 (range: 0-5) for Piver II group and 1 (range: 0-4) for Schauta group (p=0.607)) and about histotype and stage of the cervical cancer (34 patients with squamous cell carcinoma among Piver II Group vs 16 patients from Schauta Group; 4 women with adenocarcinoma from Piver II Group vs 1 subject from the Schauta Group; p value 1.000). Among the two groups there were significant statistical differences regarding the mean operative time (86 ± 28 minutes for Vaginal surgery and 115 ± 31 minutes for Abdominal surgery, p=0.038) and the average hospital stay (8.65 ± 4.42 days for abdominal surgery and 5.65 ± 2.3 days for vaginal surgery, p=0.020). Significant statistical difference was reported as regarding adjuvant RT, increased in the Piver II group with respect to the Schauta group (22 vs 4 pts; p=0.028). The survival rate at 5-years was without significant difference between the two groups (23 patients frof Piver II Group vs 11 patients from Schauta Group, p=0.510). DISCUSSION: This study confirms the benefits of the Schauta-Amreich vaginal radical hysterectomy in terms of hospital stay, mean operative time and early complications. CONCLUSION: We believe that this surgery is a plausible alternative to radical abdominal hysterectomy and could be considered to be a valid approach for the treatment of patients with cervical neoplasms, but still randomized trials are needed on this topic with respect to the ethical issues involved.
format Online
Article
Text
id pubmed-3884790
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Master Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-38847902014-04-07 Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer Larciprete, Giovanni Malandrenis, Ioannis Pierro, Giuseppe Di Montagnoli, Carlotta Rossi, Federica Centonze, Chiara Bompiani, Alessandro Panetta, Valentina Valli, Edoardo Segatore, Mario Valensise, Herbert Cirese, Elio Int J Biomed Sci Original Article INTRODUCTION: The aim of this study was to compare two groups of patients with early stage cervical cancer who underwent either abdominal or vaginal surgery, in terms of post-operative findings and survival. MATERIALS AND METHODOLOGY: 55 patients with diagnosed cervical cancer were retrospectively selected for this study. They were preoperatively staged according to FIGO criteria. Forty four patients had disease between stages Ib and IIa with no evidence of extra-pelvic lymph node involvement and 10 patients had stage ≥ IIb. RESULTS: Of the 55 patients, 17 had been operated by Schauta-Amreich radical vaginal hysterectomy and 38 by Piver type II abdominal hysterectomy. No significant statistical differences have been found between two groups about age (median age was 49 for Schauta and 54 for Piver p=0.494) and parity of the patients (Median parity was 2 (range: 0-5) for Piver II group and 1 (range: 0-4) for Schauta group (p=0.607)) and about histotype and stage of the cervical cancer (34 patients with squamous cell carcinoma among Piver II Group vs 16 patients from Schauta Group; 4 women with adenocarcinoma from Piver II Group vs 1 subject from the Schauta Group; p value 1.000). Among the two groups there were significant statistical differences regarding the mean operative time (86 ± 28 minutes for Vaginal surgery and 115 ± 31 minutes for Abdominal surgery, p=0.038) and the average hospital stay (8.65 ± 4.42 days for abdominal surgery and 5.65 ± 2.3 days for vaginal surgery, p=0.020). Significant statistical difference was reported as regarding adjuvant RT, increased in the Piver II group with respect to the Schauta group (22 vs 4 pts; p=0.028). The survival rate at 5-years was without significant difference between the two groups (23 patients frof Piver II Group vs 11 patients from Schauta Group, p=0.510). DISCUSSION: This study confirms the benefits of the Schauta-Amreich vaginal radical hysterectomy in terms of hospital stay, mean operative time and early complications. CONCLUSION: We believe that this surgery is a plausible alternative to radical abdominal hysterectomy and could be considered to be a valid approach for the treatment of patients with cervical neoplasms, but still randomized trials are needed on this topic with respect to the ethical issues involved. Master Publishing Group 2013-12 /pmc/articles/PMC3884790/ /pubmed/24711756 Text en © Giovanni Larciprete et al. Licensee Master Publishing Group http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Larciprete, Giovanni
Malandrenis, Ioannis
Pierro, Giuseppe Di
Montagnoli, Carlotta
Rossi, Federica
Centonze, Chiara
Bompiani, Alessandro
Panetta, Valentina
Valli, Edoardo
Segatore, Mario
Valensise, Herbert
Cirese, Elio
Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer
title Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer
title_full Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer
title_fullStr Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer
title_full_unstemmed Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer
title_short Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer
title_sort schauta-amreich operation vs piver ii procedure with pelvic lymphadenectomy for cervical cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884790/
https://www.ncbi.nlm.nih.gov/pubmed/24711756
work_keys_str_mv AT larcipretegiovanni schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT malandrenisioannis schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT pierrogiuseppedi schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT montagnolicarlotta schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT rossifederica schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT centonzechiara schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT bompianialessandro schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT panettavalentina schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT valliedoardo schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT segatoremario schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT valensiseherbert schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer
AT cireseelio schautaamreichoperationvspiveriiprocedurewithpelviclymphadenectomyforcervicalcancer